These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27558603)

  • 1. An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3.
    Alaei S; Knaupp AS; Lim SM; Chen J; Holmes ML; Änkö ML; Nefzger CM; Polo JM
    Stem Cell Res; 2016 Jul; 17(1):49-53. PubMed ID: 27558603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
    Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
    Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
    Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
    Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
    Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
    Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
    Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
    Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
    Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
    Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction.
    Liu X; Chen J; Firas J; Paynter JM; Nefzger CM; Polo JM
    Methods Mol Biol; 2019; 1940():63-76. PubMed ID: 30788818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
    Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
    Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
    Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
    Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.